HRT Financial’s Mesoblast MESO Stock Holding History

HRT Financial’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-34,223	Closed	-$526K	–	4898
2026 Q1	$526K	Buy	+34,223	New	+$570K	﹤0.01%	2484
2024 Q2	–	Sell	-57,815	Closed	-$289K	–	2738
2024 Q1	$289K	Buy	+57,815	New	+$123K	﹤0.01%	1573

Other funds holding MESO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

FFA

Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return

HRT Financial's MESO Position: Q2 2026 in Review

HRT Financial sold out of Mesoblast (MESO) in Q2 2026, closing a stake of 34,223 shares — an estimated $526K sold.

HRT Financial first reported a position in MESO in Q1 2024 and held it in 2 quarters. The position peaked at $526K in Q1 2026. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

HRT Financial reported no remaining Mesoblast position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 34,223 Mesoblast shares in Q2 2026, an estimated $526K.
HRT Financial first reported a position in Mesoblast in Q1 2024 and held it in 2 quarters.
HRT Financial's Mesoblast position peaked at $526K in Q1 2026.
72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.